Biopharmaceutical company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $560,000 | |
| 2025 | ARDELYX, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $580,000 | |
| 2025 | ARDELYX, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $650,000 | |
| 2025 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $620,000 | |
| 2025 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $620,000 | |
| 2025 | ARDELYX, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $540,000 | |
| 2025 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $620,000 | |
| 2024 | ARDELYX, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $670,000 | |
| 2024 | ARDELYX, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $720,000 | |
| 2024 | ARDELYX, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $530,000 |
| Client | Filings | Total Income |
|---|---|---|
| ARDELYX, INC. | 26 | — |